Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JB

James F. Blake — 118 Patents

ABArray Biopharma: 105 patents #1 of 335Top 1%
Genentech: 25 patents #82 of 2,392Top 4%
Pfizer: 8 patents #652 of 5,153Top 15%
MTMirati Therapeutics: 7 patents #9 of 63Top 15%
LOLoxo Oncology: 5 patents #9 of 31Top 30%
RARoche Palo Alto: 2 patents #157 of 347Top 50%
VIVertex Pharmaceuticals Incorporated: 2 patents #526 of 896Top 60%
Eli Lilly: 1 patents #1,752 of 2,858Top 65%
Indianapolis, IN: #8 of 5,011 inventorsTop 1%
Indiana: #39 of 33,936 inventorsTop 1%
Overall (All Time): #10,312 of 4,157,543Top 1%
118 Patents All Time
James F. Blake has been granted 118 US patents while listed as an inventor at Array Biopharma. The first was granted in 2000 and the most recent in July 2025. James F. Blake ranks #10,312 of 4,157,543 US inventors in our database (top 0.25%). Patent records list James F. Blake in Indianapolis, IN, US.

Issued Patents All Time

Showing 1–25 of 118 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12351571 Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases Li Ren, David A. Moreno, Shane M. Walls 2025-07-08
12187721 Protein tyrosine phosphatase inhibitors Mark Laurence Boys, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed, Jay Bradford Fell +6 more 2025-01-07
12180207 Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases David A. Moreno, Li Ren, Tony P. Tang, Shane M. Walls 2024-12-31
11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, Barbara J. Brandhuber, Adam Cook, Julia Haas +9 more 2024-06-04
11964988 Fused heterocyclic compounds as RET kinase inhibitors Donghua Dai, Julia Haas, Yutong Jiang, Dean Russell Kahn, Gabrielle R. Kolakowski +9 more 2024-04-23
11964989 KRas G12D inhibitors Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more 2024-04-23
11932633 KRas G12C inhibitors Matthew Arnold Marx, Matthew Lee, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +5 more 2024-03-19
11884664 Protein tyrosine phosphatase inhibitors Mark Laurence Boys, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed, Jay Bradford Fell +7 more 2024-01-30
11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors Steven W. Andrews, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski, David A. Moreno +2 more 2023-12-26
11802127 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, Mark Laurence Boys, Joshua Ryan Dahlke, Alex Andrew KELLUM +3 more 2023-10-31 $284,263,000
11691973 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, Sydney Taylor BLANCHE, Mark Laurence Boys, Wesley Dewitt CLARK +9 more 2023-07-04
11648243 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, Barbara J. Brandhuber, James Collier, Adam Cook +12 more 2023-05-16
11634417 Protein tyrosine phosphatase inhibitors Mark Laurence Boys, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed, Jay Bradford Fell +7 more 2023-04-25
11603374 Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors Donghua Dai, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski, Elizabeth A. McFaddin +6 more 2023-03-14
11524963 Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors Donghua Dai, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski, Andrew T. Metcalf +3 more 2022-12-13
11472802 Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors Shane M. Walls, Li Ren, Ginelle A. Ramann, David A. Moreno, Andrew T. Metcalf +6 more 2022-10-18
11453683 KRas G12D inhibitors Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more 2022-09-27
11267812 KRAS G12C inhibitors John P. Fischer, Jay Bradford Fell, Ronald Jay Hinklin, Macedonio J. Mejia, Erik James Hicken +10 more 2022-03-08
11168090 Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors Steven W. Andrews, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski, David A. Moreno +2 more 2021-11-09
10966985 Macrocyclic compounds as ROS1 kinase inhibitors Steven W. Andrews, Julia Haas, Gabrielle R. Kolakowski 2021-04-06
10953005 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, Barbara J. Brandhuber, Adam Cook, Julia Haas +9 more 2021-03-23
10907215 Point mutations in TRK inhibitor-resistant cancer and methods relating to the same Nisha Nanda, Joshua H. Bilenker, Gabrielle R. Kolakowski, Barbara J. Brandhuber, Steven W. Andrews 2021-02-02
10889589 Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain Shelley Allen, Steven W. Andrews, Barbara J. Brandhuber, Julia Haas, Yutong Jiang +4 more 2021-01-12
10881652 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, Barbara J. Brandhuber, James Collier, Adam Cook +12 more 2021-01-05
10766881 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Steven W. Andrews, Adam Cook, Indrani W. Gunawardana, Kevin W. Hunt, Andrew T. Metcalf +3 more 2020-09-08